Tapewire

Nasdaq · USD

VSTM

Verastem, Inc.

Export transactions ↓
Tapewire entity
5242
SEC CIK
0001526119
Parsed reports
312

Last 12 months

Inside the activity.

0 purchase rows · 33 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202509
Dec 2025013
Jan 202602
Feb 202601
Mar 202600
Apr 202600
May 202601
Jun 202603
Jul 202600
Aug 202601
Sep 202601
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 833 Not disclosed Strike: $29.76 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 4

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 833 shares

Expires 2030-04-01

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F5 · derivative.exercise_date: The canceled option was granted on April 1, 2020 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 1,666 Not disclosed Strike: $15.96 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 3

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,666 shares

Expires 2029-12-20

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F4 · derivative.exercise_date: The canceled option was granted on December 20, 2019 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 833 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 2

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 833 shares

Expires 2029-06-21

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F3 · derivative.exercise_date: The canceled option was granted on June 21, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 12.5% of the shares underlying the option on each successive three month period after such date until the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 631 Not disclosed Strike: $43.32 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 1

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 631 shares

Expires 2029-01-02

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F2 · derivative.exercise_date: The canceled option was granted on January 2, 2019 and provided for vesting as to 20% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 5.0% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fifth anniversary of the grant date.

Read SEC document
February 06, 2024 Filed Feb 7, 2024 21:00 UTC SaleCommon Stock 9,204 $13.70 $126,094.80
Disclosure

SEC source: 0001104659-24-011598 · tm245463-1_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,804

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.50 through $13.97, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:00 UTC SaleCommon Stock 9,204 $10.95 $100,783.80
Disclosure

SEC source: 0001104659-24-004453 · tm243349-1_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,008

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Table I Column 4. is a weighted average price. These shares were sold in multiple transactions ranging from $10.75 through $11.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 21:03 UTC
Calkins DanielChief Financial Officer
SaleCommon Stock 6 $8.50 $51.00
Disclosure

SEC source: 0001104659-24-002584 · tm242486-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,621

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

F2 · balance_after: Includes 277 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 21:04 UTC
Calkins DanielChief Financial Officer
SaleCommon Stock 25 $8.08 $202.00
Disclosure

SEC source: 0001104659-23-130044 · tm2333888-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,350

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 20, 2023 Filed Dec 21, 2023 21:01 UTC
Calkins DanielChief Financial Officer
SaleCommon Stock 57 $7.93 $452.01
Disclosure

SEC source: 0001104659-23-128190 · tm2333521-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,375

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 19, 2023 Filed Dec 20, 2023 21:00 UTC SaleCommon Stock 274 $7.73 $2,118.02
Disclosure

SEC source: 0001104659-23-127723 · tm2333364-1_4seq1.xml · nonDerivative · entry 2

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,450

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 19, 2023 Filed Dec 20, 2023 21:03 UTC SaleCommon Stock 130 $7.73 $1,004.90
Disclosure

SEC source: 0001104659-23-127726 · tm2333364-3_4seq1.xml · nonDerivative · entry 2

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,212

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 19, 2023 Filed Dec 20, 2023 21:01 UTC
Paterson DanDirector · President and CEO
SaleCommon Stock 183 $7.73 $1,414.59
Disclosure

SEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,916

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 21:00 UTC SaleCommon Stock 487 $7.64 $3,720.68
Disclosure

SEC source: 0001104659-23-127723 · tm2333364-1_4seq1.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,724

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 21:03 UTC SaleCommon Stock 284 $7.64 $2,169.76
Disclosure

SEC source: 0001104659-23-127726 · tm2333364-3_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,342

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 21:01 UTC
Paterson DanDirector · President and CEO
SaleCommon Stock 244 $7.64 $1,864.16
Disclosure

SEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,099

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
October 24, 2023 Filed Oct 26, 2023 20:28 UTC
Calkins DanielChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $6.89 $0.00
Disclosure

SEC source: 0001104659-23-111753 · tm2329107-1_4seq1.xml · derivative · entry 1

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-10-24

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of October 24, 2023 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 20:31 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 5 $7.30 $36.50
Disclosure

SEC source: 0001104659-23-108316 · tm2328003-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,432

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 25, 2023 Filed Sep 25, 2023 20:46 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 25 $9.40 $235.00
Disclosure

SEC source: 0001104659-23-103536 · tm2326760-1_4seq1.xml · nonDerivative · entry 2

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,437

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 20:46 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 232 $9.31 $2,159.92
Disclosure

SEC source: 0001104659-23-103536 · tm2326760-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,462

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 19, 2023 Filed Sep 20, 2023 20:15 UTC SaleCommon Stock 274 $9.84 $2,696.16
Disclosure

SEC source: 0001104659-23-102296 · tm2326467-1_4seq1.xml · nonDerivative · entry 2

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,211

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 19, 2023 Filed Sep 20, 2023 20:15 UTC SaleCommon Stock 130 $9.84 $1,279.20
Disclosure

SEC source: 0001104659-23-102298 · tm2326467-2_4seq1.xml · nonDerivative · entry 2

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,626

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 19, 2023 Filed Sep 20, 2023 20:15 UTC
Paterson DanDirector · President and CEO
SaleCommon Stock 183 $9.84 $1,800.72
Disclosure

SEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,343

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 18, 2023 Filed Sep 20, 2023 20:15 UTC SaleCommon Stock 478 $9.91 $4,736.98
Disclosure

SEC source: 0001104659-23-102296 · tm2326467-1_4seq1.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,485

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 18, 2023 Filed Sep 20, 2023 20:15 UTC SaleCommon Stock 278 $9.91 $2,754.98
Disclosure

SEC source: 0001104659-23-102298 · tm2326467-2_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,756

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 18, 2023 Filed Sep 20, 2023 20:15 UTC
Paterson DanDirector · President and CEO
SaleCommon Stock 240 $9.91 $2,378.40
Disclosure

SEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,526

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:40 UTC
Paterson DanDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $10.44 $0.00
Disclosure

SEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-08-02

F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of August 2, 2023 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:40 UTC
Paterson DanDirector · President and CEO
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,766

F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of August 2, 2023 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
July 06, 2023 Filed Jul 10, 2023 20:05 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 5 $8.02 $40.10
Disclosure

SEC source: 0001104659-23-079653 · tm2320874-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,694

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

F2 · balance_after: Includes 277 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan.

Read SEC document
June 26, 2023 Filed Jun 28, 2023 20:11 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 26 $8.17 $212.42
Disclosure

SEC source: 0001104659-23-075801 · tm2319848-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,422

F1 · shares: - The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:23 UTC
Stuglik Brian MDirector · Chief Executive Officer
SaleCommon Stock 275 $10.30 $2,832.50
Disclosure

SEC source: 0001104659-23-073360 · tm2319280-1_4seq1.xml · nonDerivative · entry 2

Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,963

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:24 UTC SaleCommon Stock 130 $10.30 $1,339.00
Disclosure

SEC source: 0001104659-23-073362 · tm2319280-2_4seq1.xml · nonDerivative · entry 2

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,034

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:25 UTC
Paterson DanPresident and COO
SaleCommon Stock 183 $10.30 $1,884.90
Disclosure

SEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,766

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:23 UTC
Stuglik Brian MDirector · Chief Executive Officer
SaleCommon Stock 487 $9.92 $4,831.04
Disclosure

SEC source: 0001104659-23-073360 · tm2319280-1_4seq1.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,238

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:24 UTC SaleCommon Stock 283 $9.92 $2,807.36
Disclosure

SEC source: 0001104659-23-073362 · tm2319280-2_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,164

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:25 UTC
Paterson DanPresident and COO
SaleCommon Stock 244 $9.92 $2,420.48
Disclosure

SEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,949

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:31 UTC GrantStock Option (right to buy) · Derivative 187,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061414 · tm2315836-2_4seq1.xml · derivative · entry 1

Tollefson Karin Anna · CIK 0001976551 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,500

Underlying: Common Stock · 187,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: 125,000 of the stock options vest in twelve equal quarterly installments beginning each three successive month period following May 15, 2023 (the "Option Grant Date") until the third anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest).

F2 · derivative.exercise_date: 62,500 of the stock options vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:32 UTC GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061415 · tm2315836-3_4seq1.xml · derivative · entry 1

ROBERTSON MICHELLE · CIK 0001755098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:33 UTC
JOHNSON JOHNDirector
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061421 · tm2315836-5_4seq1.xml · derivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:35 UTC GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061427 · tm2315836-8_4seq1.xml · derivative · entry 1

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:34 UTC GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061426 · tm2315836-7_4seq1.xml · derivative · entry 1

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:32 UTC GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061419 · tm2315836-4_4seq1.xml · derivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:36 UTC
Bunn Paul A.Director
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061429 · tm2315836-9_4seq1.xml · derivative · entry 1

Bunn Paul A. · CIK 0001868760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:34 UTC
Kapur AnilDirector
GrantStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001104659-23-061424 · tm2315836-6_4seq1.xml · derivative · entry 1

Kapur Anil · CIK 0001730703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-05-15

F1 · derivative.exercise_date: The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date.

Read SEC document
April 05, 2023 Filed Apr 6, 2023 20:30 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 75 $0.37 $27.75
Disclosure

SEC source: 0001104659-23-042752 · tm2311917-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,397

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 20:30 UTC
Calkins DanielVice President of Finance
SaleCommon Stock 378 $0.42 $158.76
Disclosure

SEC source: 0001104659-23-037743 · tm2310686-1_4seq1.xml · nonDerivative · entry 1

Calkins Daniel · CIK 0001951861 · Vice President of Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,472

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

F2 · balance_after: Includes 3,333 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan.

Read SEC document
March 20, 2023 Filed Mar 20, 2023 20:54 UTC
Stuglik Brian MDirector · Chief Executive Officer
SaleCommon Stock 3,508 $0.43 $1,508.44
Disclosure

SEC source: 0001104659-23-034507 · tm239927-1_4seq1.xml · nonDerivative · entry 2

Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,112,736

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 20, 2023 20:59 UTC SaleCommon Stock 1,664 $0.43 $715.52
Disclosure

SEC source: 0001104659-23-034515 · tm239927-3_4seq1.xml · nonDerivative · entry 2

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 569,399

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 20, 2023 20:57 UTC
Paterson DanPresident and COO
SaleCommon Stock 2,339 $0.43 $1,005.77
Disclosure

SEC source: 0001104659-23-034510 · tm239927-2_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,351

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 16, 2023 Filed Mar 20, 2023 20:54 UTC
Stuglik Brian MDirector · Chief Executive Officer
SaleCommon Stock 6,276 $0.40 $2,510.40
Disclosure

SEC source: 0001104659-23-034507 · tm239927-1_4seq1.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,116,244

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 16, 2023 Filed Mar 20, 2023 20:59 UTC SaleCommon Stock 3,654 $0.40 $1,461.60
Disclosure

SEC source: 0001104659-23-034515 · tm239927-3_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 571,063

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.